Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 7

1.

Azathioprine therapy selectively ablates human Vδ2⁺ T cells in Crohn's disease.

McCarthy NE, Hedin CR, Sanders TJ, Amon P, Hoti I, Ayada I, Baji V, Giles EM, Wildemann M, Bashir Z, Whelan K, Sanderson I, Lindsay JO, Stagg AJ.

J Clin Invest. 2015 Aug 3;125(8):3215-25. doi: 10.1172/JCI80840. Epub 2015 Jul 13.

2.

Systemic Inflammatory Response Syndrome After Major Abdominal Surgery Predicted by Early Upregulation of TLR4 and TLR5.

Lahiri R, Derwa Y, Bashir Z, Giles E, Torrance HD, Owen HC, O'Dwyer MJ, O'Brien A, Stagg AJ, Bhattacharya S, Foster GR, Alazawi W.

Ann Surg. 2016 May;263(5):1028-37. doi: 10.1097/SLA.0000000000001248.

PMID:
26020106
3.

Increased production of retinoic acid by intestinal macrophages contributes to their inflammatory phenotype in patients with Crohn's disease.

Sanders TJ, McCarthy NE, Giles EM, Davidson KL, Haltalli ML, Hazell S, Lindsay JO, Stagg AJ.

Gastroenterology. 2014 May;146(5):1278-88.e1-2. doi: 10.1053/j.gastro.2014.01.057. Epub 2014 Feb 4.

PMID:
24503130
4.

Proinflammatory Vδ2+ T cells populate the human intestinal mucosa and enhance IFN-γ production by colonic αβ T cells.

McCarthy NE, Bashir Z, Vossenkämper A, Hedin CR, Giles EM, Bhattacharjee S, Brown SG, Sanders TJ, Whelan K, MacDonald TT, Lindsay JO, Stagg AJ.

J Immunol. 2013 Sep 1;191(5):2752-63. doi: 10.4049/jimmunol.1202959. Epub 2013 Jul 31.

5.

Optimal assessment of paediatric IBD with MRI and barium follow-through.

Giles E, Hanci O, McLean A, Power N, Cole A, Croft NM, McDonald K, Chippington S, Naik S.

J Pediatr Gastroenterol Nutr. 2012 Jun;54(6):758-62. doi: 10.1097/MPG.0b013e3182460111.

PMID:
22588598
6.

EWTD: incompatible with subspecialty training?

Giles E, Hansen R, Barclay AR, Burtt A, Bremner R, Sullivan PB, Beattie RM.

Arch Dis Child. 2011 Jul;96(7):699-700. doi: 10.1136/adc.2010.208389. Epub 2011 Jan 24. No abstract available.

PMID:
21266340
7.

The utility of Tc-99m dextran in the diagnosis and identification of melanoma metastases responsible for protein-losing enteropathy.

Sivaratnam DA, Pitman AG, Giles E, Lichtenstein M.

Clin Nucl Med. 2002 Apr;27(4):243-5.

PMID:
11914661
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk